BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 21, 2025
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist
Nov. 12, 1997
FDA review of Myotrophin continues after resubmission
Nov. 12, 1997
New neuroprotectants disclosed by Nippon Shinyaku
Nov. 12, 1997
Atypical antipsychotic developed at Esteve characterized
Nov. 11, 1997
Azolobenzazepines claimed by Zeneca for use in stroke
Nov. 11, 1997
Fujisawa reports heterocyclic glutamate receptor antagonists
Nov. 11, 1997
Neurogen describes dopamine receptor subtype-specific ligands
Nov. 11, 1997
Phase Ia study with NGD-91-2 completed
Nov. 10, 1997
Prionics develops antibody useful for diagnosing and possibly treating prion diseases
Nov. 10, 1997
Quinoxalinediones for neurodegenerative/neurological disorders patented
Nov. 10, 1997
Previous
1
2
…
2783
2784
2785
2786
2787
2788
2789
2790
2791
…
2940
2941
Next
RSS